Choice - Best Stock Broker in India
  • About
  • App
  • Services
    Services
  • Research
  • Partners
  • Contact
  • Log In
  • Open Demat Account
  • Home
  • Blog
  • ...
  • KIMS Hospitals Announces Expansion of 350 beds New Super Specialty Hospital in Bengaluru
  • ...
    KIMS Hospitals Announces Expansion of 350 beds New Super Specialty Hospital in Bengaluru

KIMS Hospitals Announces Expansion of 350 beds New Super Specialty Hospital in Bengaluru

KIMS Hospitals Announces Expansion of 350 beds New Super Specialty Hospital in Bengaluru
  • Published Date: May 31, 2024
  • Updated Date: May 31, 2024
  • By Team Choice
The hospital will be located at the PES University campus in Electronic City and managed by KIMS under a 25-year lease agreement.

KIMS Hospital has entered into a lease agreement for setting up a Super Specialty Hospital in Bengaluru, Karnataka, at Peoples Education Society (PES) campus, Electronic City along with management of the Super Specialty Hospital.

PES is a university of repute and conducts several educational courses in various parts of the country. PES is in the process of setting up a medical college along with a teaching hospital at its campus at Electronics City, Bengaluru PES is developing the structure to house a hospital with about 350 beds. It consists of 11 upper floors and a ground floor, totaling 3,50,000 square feet of built-up area. There is also a utility room and a radiation oncology bunker. KIMS Hospital Bengaluru Pvt. Ltd, a subsidiary of Krishna Institute of Medical Sciences Limited (KIMS) entered into a lease deed of 25 years and availed on lease the land and hospital building, for the purposes of setting up the Super Specialty Hospital from PES.

KIMS Hospital Bengaluru Private Limited (“the KIMS”), a wholly-owned subsidiary of Krishna Institute of Medical Sciences Limited also entered into a management agreement with PES to exclusively manage the proposed under-construction hospital unit at Electronics City, Bengaluru. The Super Specialty Hospital will be managed properly and efficiently by KIMS, which will have exclusive oversight and control over it. All Super Specialty Hospital revenues will be billed to and collected by KIMS, which will also bear the hospital's operating costs. KIMS shall be solely entitled to the Net Profits of the Super Specialty Hospital in each Financial Year.

Recommended for you

loading

Understanding XIRR in Mutual Funds: A Detailed Guide

loading

Yamini Investments Company Ltd Right Issue 2025

loading

Trans India House Impex Ltd Right Issue 2025

loading

Crude Oil Price Forecast for Next Week

Choice Financial Services
  • Services

  • Broking & Distribution
  • Wealth Planning
  • Insurance
  • Loans
  • Capital Advisory
  • Management Consultancy
  • Government Advisory
  • Tax Advisory
  • Company

  • Our Team
  • Investors
  • Calculator
  • Careers
  • Contact Us
  • Refer & Earn
  • FAQ’s
  • Resources

  • Fundamental
  • Technical
  • Blog
  • Pricing
  • Downloads
  • News & Media
  • Offer Document
  • Track Record
  • Investor Charter
  • Investor Grievances
  • Online KYC Updation
  • Quick Links

  • Open Demat Account
  • Corporate Demat Account
  • NRI Demat Account
  • Minor Demat Account
  • Lowest Brokerage
  • Investor Charter
  • Investor Awareness
  • Watchout Investors
  • Investor's Advisory
  • Disclaimer
  • CEBPL Policies & Disclosures
  • CFPL Policies & Disclosures
  • Sachet Portal
  • Direct Pay-in

Choice International Limited , Sunil Patodia Tower,
J B Nagar, Andheri(East),
Mumbai 400099.

Monday - Friday : 08:30 am - 7:00 pm
Saturday : 10:00 am - 4:00 pm

+91-88-2424-2424

care@choiceindia.com

Google Play
App StoreApp Store
  • Made with in India
  • Privacy Policy
  • Terms & Conditions

Choiceinternational. CIN - L67190MH1993PLC071117
Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ).
Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015 , DP ID CDSL - 12066900 , NSDL ID - IN301895. Research Analyst - INH000000222
Choice Wealth Private Limited: AMFI - Registered Mutual Fund Distributor. Association of Mutual Funds in India Registration Number - ARN - 78908.
Initial Registration: 15th March 2010 Valid Till: 14th March 2027.
Pension Fund Regulatory and Development Authority (PFRDA) - POPSE52022022 | Affiliated with POP HDFC Pension Management Company.
Choice Finserv Private Limited: NBFC Registration Number : N - 13.02216

Choice Insurance Broking Private Limited: IRDAI License No: 167, License Valid Till: 29-05-2025 | Category : Direct ( Life & General )
Registered Office: Choice International Limited, Sunil Patodia Tower, J B Nagar, Andheri East, Mumbai, Maharashtra 400099.
For any Grievances / Queries email at ig@choiceindia.com & care@choiceindia.com | Online Dispute Resolution Link: https://smartodr.in/login

Cautionary Message :

  1. Sharing of trading credentials – login id & passwords including OTP’s:- Keep Your Password/Pin and OTP’s private & confidential to avoid any misuse or unauthorised trades. Please ensure that you do not share it with any one.
  2. Trading in leveraged products like options without proper understanding, which could lead to losses
  3. Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks
  4. Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  5. Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers

Disclaimer:
1. *Investments in securities market are subject to market risks, read all the related documents carefully before investing.
2. In addition to client based business, we are also doing proprietary trading.
3. Brokerage will not exceed the SEBI prescribed limit.

Research Disclaimer and Disclosure inter-alia as required under Securities and Exchange Board of India (Research Analysts) Regulations, 2014

Choice Equity Broking Private Limited (“CEBPL”) is a registered Research Analyst Entity (Reg. No. INH000000222 ) (hereinafter be referred as “CEBPL”). (CIN. NO.: U65999MH2010PTC198714).

Reg. Address: Sunil Patodia Tower, J B Nagar, Andheri(East), Mumbai 400099. Tel. No. 022-6707 9999 .

Compliance Officer: Mr.Prashant Salian. Tel. 022-67079999 - Ext-2310
Email- Prashant.salian@choiceindia.com

Grievance officer: Deepika Singhvi Tel.022-67079999- Ext-834.
Email- ig@choiceindia.com

Research Disclaimer: Investment in the securities market is subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© Choice International Limited. All Rights Reserved.